- Home
- OXM vs RCKT Comparison
OXM vs RCKT Comparison
Compare OXM & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXM
- RCKT
- Stock Information
- Founded
- OXM 1942
- RCKT 1999
- Country
- OXM United States
- RCKT United States
- Employees
- OXM N/A
- RCKT N/A
- Industry
- OXM Apparel
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- OXM Consumer Discretionary
- RCKT Health Care
- Exchange
- OXM Nasdaq
- RCKT Nasdaq
- Market Cap
- OXM 672.2M
- RCKT 764.5M
- IPO Year
- OXM N/A
- RCKT N/A
- Fundamental
- Price
- OXM $55.19
- RCKT $7.18
- Analyst Decision
- OXM Hold
- RCKT Strong Buy
- Analyst Count
- OXM 5
- RCKT 10
- Target Price
- OXM $59.00
- RCKT $44.10
- AVG Volume (30 Days)
- OXM 431.3K
- RCKT 3.2M
- Earning Date
- OXM 06-11-2025
- RCKT 05-08-2025
- Dividend Yield
- OXM 5.19%
- RCKT N/A
- EPS Growth
- OXM 53.66
- RCKT N/A
- EPS
- OXM 5.87
- RCKT N/A
- Revenue
- OXM $1,516,601,000.00
- RCKT N/A
- Revenue This Year
- OXM N/A
- RCKT N/A
- Revenue Next Year
- OXM $2.59
- RCKT N/A
- P/E Ratio
- OXM $9.06
- RCKT N/A
- Revenue Growth
- OXM N/A
- RCKT N/A
- 52 Week Low
- OXM $42.12
- RCKT $4.55
- 52 Week High
- OXM $111.46
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- OXM 56.30
- RCKT 46.92
- Support Level
- OXM $46.83
- RCKT $6.21
- Resistance Level
- OXM $53.20
- RCKT $8.26
- Average True Range (ATR)
- OXM 2.44
- RCKT 0.58
- MACD
- OXM 1.24
- RCKT 0.03
- Stochastic Oscillator
- OXM 96.92
- RCKT 28.05
About OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.